Related Experiment Video

Updated: Sep 4, 2025

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

3.8K

Drug Target Prediction Using Context-Specific Metabolic Models Reconstructed from rFASTCORMICS

Tamara Bintener1, Maria Pires Pacheco1, Ali Kishk1

  • 1Department of Life Sciences and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Methods in Molecular Biology (Clifton, N.J.)
|July 22, 2022
PubMed

Insights

This study details cancer metabolic modeling using rFASTCORMICS to identify drug repurposing candidates. It presents a workflow for predicting effective cancer drugs through context-specific metabolic models.

Area of Science:

  • Computational biology
  • Systems biology
  • Cancer research

Background:

  • Metabolic modeling is a key computational approach for understanding cellular metabolism.
  • It aids in identifying metabolic alterations in cancer and predicting therapeutic targets.
  • Drug repurposing offers a faster route to identify new cancer treatments.

Purpose of the Study:

  • To elaborate on reconstructing cancer-specific metabolic models using rFASTCORMICS.
  • To present a drug prediction workflow for identifying candidate drugs for repurposing in cancer.

Main Methods:

  • Reconstruction of context-specific metabolic models for cancer.
  • Utilizing the rFASTCORMICS computational tool.
  • Application of a drug prediction workflow for repurposing candidate identification.

Main Results:

  • Demonstration of rFASTCORMICS for creating detailed cancer metabolic models.
  • Successful application of the drug prediction workflow to identify potential repurposed drugs.
  • Highlighting the utility of metabolic modeling in cancer drug discovery.

Conclusions:

  • Context-specific metabolic models are crucial for understanding cancer metabolism.
  • The presented workflow effectively predicts drugs for repurposing in cancer treatment.
  • Metabolic modeling provides a powerful strategy for accelerating cancer drug development.
Keywords:
CancerDrug predictionDrug repurposingMetabolic Modelling

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K
A Protocol for Computer-Based Protein Structure and Function Prediction16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.8K

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
136
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
107
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
8.6K